PSMA binding ligand-linker conjugates and methods for using
PS Low, SA Kularatne - US Patent 10,046,054, 2018 - Google Patents
Described herein are prostate specific membrane antigen (PSMA) binding conjugates that
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …
PSMA binding ligand-linker conjugates and methods for using
PS Low, V Chelvam, Y Kim, SA Kularatne - US Patent 9,951,324, 2018 - Google Patents
4, 691, 024 A 9/1987 Kunikatsu et al. 4, 713, 249 A 12/1987 Schroder 5, 103, 018 A 4/1992
Motomichi et al. 5, 266, 333 A 11/1993 Cady et al. 5, 418, 982 A 5/1995 Kishi 5, 627, 165 A …
Motomichi et al. 5, 266, 333 A 11/1993 Cady et al. 5, 418, 982 A 5/1995 Kishi 5, 627, 165 A …
PSMA binding ligand-linker conjugates and methods for using
PS Low, SA Kularatne - US Patent 10,624,970, 2020 - Google Patents
Described herein are prostate specific membrane antigen (PSMA) binding conjugates that
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …
PSMA binding ligand-linker conjugates and methods for using
PS Low, SA Kularatne - US Patent 10,517,956, 2019 - Google Patents
Described herein are prostate specific membrane antigen (PSMA) binding conjugates that
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …
PSMA binding ligand-linker conjugates and methods for using
PS Low, SA Kularatne - US Patent 10,624,971, 2020 - Google Patents
Described herein are prostate specific membrane antigen (PSMA) binding conjugates that
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …
PSMA binding ligand-linker conjugates and methods for using
PS Low, SA Kularatne - US Patent 10,646,581, 2020 - Google Patents
Described herein are prostate specific membrane antigen (PSMA) binding conjugates that
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …
PSMA binding ligand-linker conjugates and methods for using
PS Low, SA Kularatne - US Patent 10,485,878, 2019 - Google Patents
Described herein are prostate specific membrane antigen (PSMA) binding conjugates that
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …
PSMA binding ligand-linker conjugates and methods for using
PS Low, SA Kularatne - US Patent 10,624,969, 2020 - Google Patents
Described herein are prostate specific membrane antigen (PSMA) binding conjugates that
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …
PSMA binding ligand-linker conjugates and methods for using
PS Low, SA Kularatne - US Patent 10,517,957, 2019 - Google Patents
Described herein are prostate specific membrane antigen (PSMA) binding conjugates that
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …
PSMA binding ligand-linker conjugates and methods for using
PS Low, SA Kularatne - US Patent 10,406,240, 2019 - Google Patents
7, 147, 837 B2 12/2006 Lauffer et al. 7, 192, 586 B2 3/2007 Bander 7, 232, 805 B2 6/2007
Weinshenker et al. 7, 361, 338 B2 4/2008 Jakobovits et al. 7, 381, 745 B2 6/2008 …
Weinshenker et al. 7, 361, 338 B2 4/2008 Jakobovits et al. 7, 381, 745 B2 6/2008 …